What We're Reading: Page 239
Industry reads hand-picked by our editors
Oct 25, 2018
Oct 24, 2018
-
Axios
Express Scripts to open up mail-order pharmacy network
-
Harvard Business Review
How Lilly Is Getting More Women into Leadership Positions
-
Financial Times
Fast-track flu vaccine raises hopes for quicker drugs approvals
Oct 23, 2018
-
The Wall Street Journal
The Illegal Ingredients in Your Dietary Supplements - WSJ
-
BioCentury
FDA advisory committee to consider CV studies for diabetes drugs
-
STAT
Mallinckrodt will be honored for research into a drug that causes sticker shock
-
Reuters
Johnson & Johnson makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z
Oct 22, 2018
-
The Wall Street Journal
A Billionaire Pledges to Fight High Drug Prices, and the Industry Is Rattled
-
The New York TImes
What Big Pharma Fears Most: A Trump Alliance With Democrats to Cut Drug Prices
-
Reuters
Merck KGaA says might strike partnership deal this year
-
STAT
Saving Mila: How doctors raced to stop a young girl's rare disease
Oct 19, 2018
Oct 18, 2018
-
MIT Technology Review
We can now customize cancer treatments, tumor by tumor
-
Bloomberg
An ETF banking on the next big drug breakthrough
-
The Washington Post
Big Pharma is hurting drug innovation
-
Associated Press
Rising drug prices widen gap between have, have-not patients
Previous
